| May 15, 2025 |
May 19, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
53.8
|
-52
|
-0.22%
|
✓
|
$22.1K |
| Mar 13, 2025 |
Mar 17, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
20.0
|
-3,231
|
-12.19%
|
✓
|
$1.6M |
| Mar 10, 2025 |
Mar 12, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
20.0
|
-3,231
|
-10.86%
|
✓
|
$1.6M |
| Mar 3, 2025 |
Mar 5, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
23.8
|
-3,231
|
-9.80%
|
✓
|
$1.6M |
| Feb 26, 2025 |
Feb 28, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
15.0
|
-7,226
|
-17.98%
|
✓
|
$3.5M |
| Feb 24, 2025 |
Feb 26, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
20.0
|
-4,819
|
-10.70%
|
✓
|
$2.3M |
| Feb 20, 2025 |
Feb 24, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
38.8
|
-1,111
|
-2.41%
|
✓
|
$533.3K |
| Feb 14, 2025 |
Feb 19, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
17.5
|
-2,293
|
-4.74%
|
✗
|
$1.1M |
| Feb 10, 2025 |
Feb 12, 2025 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
17.5
|
-2,142
|
-4.73%
|
✗
|
$1M |
| Nov 15, 2024 |
Nov 19, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
56.3
|
-15
|
-0.06%
|
✓
|
$7.2K |
| May 15, 2024 |
May 17, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Chief Scientific Officer |
Sell |
53.8
|
-54
|
-0.21%
|
✓
|
$23.3K |
| Feb 23, 2024 |
Feb 27, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
10.0
|
-8,209
|
-24.13%
|
✓
|
$3.5M |
| Feb 21, 2024 |
Feb 23, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
23.8
|
-3,002
|
-8.11%
|
✓
|
$1.3M |
| Feb 16, 2024 |
Feb 21, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
10.0
|
-10,564
|
-22.20%
|
✓
|
$4.5M |
| Feb 9, 2024 |
Feb 13, 2024 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
23.8
|
-5,244
|
-9.93%
|
✓
|
$2.2M |
| Nov 15, 2023 |
Nov 17, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
56.3
|
-19
|
-0.06%
|
✓
|
$7K |
| Aug 9, 2023 |
Aug 11, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
53.8
|
-63
|
-0.20%
|
✓
|
$21.8K |
| Feb 24, 2023 |
Feb 28, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
10.0
|
-8,208
|
-20.39%
|
✓
|
$2.4M |
| Feb 17, 2023 |
Feb 22, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
15.0
|
-7,752
|
-16.15%
|
✓
|
$2.3M |
| Feb 14, 2023 |
Feb 16, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
20.0
|
-6,398
|
-11.76%
|
✓
|
$1.9M |
| Feb 10, 2023 |
Feb 14, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
10.0
|
-14,249
|
-20.76%
|
✓
|
$4.2M |
| Feb 6, 2023 |
Feb 8, 2023 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
42.5
|
-1,304
|
-1.86%
|
✓
|
$399K |
| Nov 15, 2022 |
Nov 17, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
55.0
|
-34
|
-0.09%
|
✓
|
$10.5K |
| Nov 7, 2022 |
Nov 9, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-1,303
|
-3.49%
|
✓
|
$394.9K |
| Aug 8, 2022 |
Aug 10, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-1,304
|
-3.49%
|
✓
|
$381.5K |
| Jul 19, 2022 |
Jul 21, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
3.8
|
-17,865
|
-33.12%
|
✓
|
$5.2M |
| Feb 24, 2022 |
Feb 28, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
5.0
|
-13,610
|
-27.39%
|
✓
|
$3.1M |
| Feb 17, 2022 |
Feb 22, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
20.0
|
-7,751
|
-13.49%
|
✓
|
$1.8M |
| Feb 14, 2022 |
Feb 16, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-2,444
|
-4.08%
|
✓
|
$567.1K |
| Feb 10, 2022 |
Feb 14, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
23.8
|
-5,815
|
-8.85%
|
✓
|
$1.4M |
| Feb 1, 2022 |
Feb 3, 2022 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
92.5
|
+27,448
|
4.51%
|
✓
|
$1.2M |
| Nov 15, 2021 |
Nov 16, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
55.0
|
-34
|
-0.10%
|
✓
|
$6.4K |
| May 17, 2021 |
May 19, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
53.8
|
-79
|
-0.23%
|
✓
|
$17.1K |
| Feb 24, 2021 |
Feb 26, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
20.0
|
-5,444
|
-13.95%
|
✓
|
$1.2M |
| Feb 17, 2021 |
Feb 19, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
5.0
|
-14,065
|
-26.49%
|
✓
|
$3M |
| Feb 11, 2021 |
Feb 16, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
23.8
|
-5,283
|
-9.05%
|
✓
|
$1.1M |
| Feb 10, 2021 |
Feb 12, 2021 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
20.0
|
-2,974
|
-4.85%
|
✗
|
$636.9K |
| Nov 16, 2020 |
Nov 18, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
55.0
|
-38
|
-0.13%
|
✓
|
$8.5K |
| Aug 6, 2020 |
Aug 10, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-1,223
|
-4.06%
|
✓
|
$331.7K |
| Aug 3, 2020 |
Aug 5, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
30.0
|
-2,330
|
-7.46%
|
✓
|
$648.3K |
| May 15, 2020 |
May 19, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
52.5
|
-82
|
-0.28%
|
✓
|
$23.3K |
| May 12, 2020 |
May 14, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-1,304
|
-4.32%
|
✓
|
$374.7K |
| May 6, 2020 |
May 8, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
35.0
|
-1,222
|
-4.06%
|
✓
|
$333.2K |
| May 4, 2020 |
May 6, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
30.0
|
-2,330
|
-7.46%
|
✓
|
$607.8K |
| Feb 24, 2020 |
Feb 26, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
15.0
|
-5,444
|
-15.85%
|
✓
|
$1.3M |
| Feb 17, 2020 |
Feb 19, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
20.0
|
-5,624
|
-14.07%
|
✓
|
$1.4M |
| Feb 10, 2020 |
Feb 12, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
3.8
|
-30,340
|
-43.15%
|
✓
|
$7.4M |
| Feb 5, 2020 |
Feb 7, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
92.5
|
+36,231
|
8.53%
|
✓
|
$604.8K |
| Feb 3, 2020 |
Feb 5, 2020 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
22.5
|
-4,126
|
-11.56%
|
✓
|
$953.9K |
| Nov 25, 2019 |
Nov 26, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
22.5
|
-3,910
|
-11.03%
|
✓
|
$857.7K |
| Nov 15, 2019 |
Nov 19, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
53.8
|
-60
|
-0.19%
|
✓
|
$12.4K |
| Nov 6, 2019 |
Nov 7, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
37.5
|
-1,223
|
-3.73%
|
✓
|
$241.2K |
| Nov 4, 2019 |
Nov 6, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
22.5
|
-4,126
|
-11.56%
|
✓
|
$827K |
| Oct 22, 2019 |
Oct 24, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
22.5
|
-3,669
|
-10.42%
|
✓
|
$713.1K |
| Aug 19, 2019 |
Aug 20, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
27.5
|
-12,501
|
-7.17%
|
✓
|
$2.3M |
| May 15, 2019 |
May 17, 2019 |
VERTEX PHARMACEUTICALS INC / MA
|
EVP, Global Research and CSO |
Sell |
52.5
|
-91
|
-0.29%
|
✓
|
$15.1K |